Occam Places CFO for Prominent Swiss Biotech Alentis
.avif)
In August 2024, Occam Global placed Jonathan Freve as Chief Financial Officer (CFO) of Alentis Therapeutics, a Jeito Capital, Novo Holdings, RA Capital, Bpifrance, and Schroders Capital investment.
Jon brings to Alentis over 20 years of financial experience in increasingly senior roles in the biotechnology sector. Most recently, he served as the CFO of Galecto, where he was responsible for leading financial operations, investor relations, and fundraising efforts. Before his role at Galecto, Jon was the CFO of Spring Bank Pharmaceuticals and held Corporate Controller positions at other publicly traded global companies.
Jon is a CPA who has worked on several successful initial public offerings, secondary offerings, mergers, and acquisitions. He holds a Bachelor’s degree in Business Administration from the University of Massachusetts Amherst.
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.